Yi-Hui Wu - Search Results

Year	Number of Results
2005	4
2007	3
2008	2
2009	2
2010	4
2011	4
2012	7
2013	7
2014	14
2015	11
2016	7
2017	6
2018	6
2019	3
2020	4
2021	3
2022	3
2023	7
2024	1

1

Clinical impact of Clostridium difficile colonization.

Hung YP, Lee JC, Lin HJ, Liu HC, Wu YH, Tsai PJ, Ko WC. Hung YP, et al. Among authors: wu yh. J Microbiol Immunol Infect. 2015 Jun;48(3):241-8. doi: 10.1016/j.jmii.2014.04.011. Epub 2014 Jun 2. J Microbiol Immunol Infect. 2015. PMID: 24890755 Free article. Review.

2

Collagen XI Alpha 1 Chain, a Novel Therapeutic Target for Cancer Treatment.

Wu YH, Chou CY. Wu YH, et al. Front Oncol. 2022 Jun 29;12:925165. doi: 10.3389/fonc.2022.925165. eCollection 2022. Front Oncol. 2022. PMID: 35847935 Free PMC article. Review.

3

A study of medical device regulation management model in Asia.

Wu YH, Li FA, Fan YT, Tu PW. Wu YH, et al. Expert Rev Med Devices. 2016 Jun;13(6):533-43. doi: 10.1080/17434440.2016.1184970. Expert Rev Med Devices. 2016. PMID: 27136699 Review.

4

Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection.

Hung YP, Lee JC, Lin HJ, Liu HC, Wu YH, Tsai PJ, Ko WC. Hung YP, et al. Among authors: wu yh. Antibiotics (Basel). 2015 Jun 19;4(2):216-29. doi: 10.3390/antibiotics4020216. Antibiotics (Basel). 2015. PMID: 27025622 Free PMC article. Review.

5

SPAK mediates KCC3-enhanced cervical cancer tumorigenesis.

Chiu MH, Liu HS, Wu YH, Shen MR, Chou CY. Chiu MH, et al. Among authors: wu yh. FEBS J. 2014 May;281(10):2353-65. doi: 10.1111/febs.12787. Epub 2014 Apr 7. FEBS J. 2014. PMID: 24655550 Free article.

6

The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells.

Wu YH, Huang YF, Wu PY, Chang TH, Huang SC, Chou CY. Wu YH, et al. J Ovarian Res. 2023 Jun 29;16(1):124. doi: 10.1186/s13048-023-01191-5. J Ovarian Res. 2023. PMID: 37386587 Free PMC article.

7

Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment.

Wu YH, Huang YF, Chen CC, Huang CY, Chou CY. Wu YH, et al. Front Pharmacol. 2020 Mar 3;11:206. doi: 10.3389/fphar.2020.00206. eCollection 2020. Front Pharmacol. 2020. PMID: 32194423 Free PMC article.

8

miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1.

Wu YH, Huang YF, Chang TH, Wu PY, Hsieh TY, Hsiao SY, Huang SC, Chou CY. Wu YH, et al. Cancers (Basel). 2021 Dec 13;13(24):6257. doi: 10.3390/cancers13246257. Cancers (Basel). 2021. PMID: 34944877 Free PMC article.

9

Verification of the beta oscillations in the subthalamic nucleus of the MPTP-induced parkinsonian minipig model.

Lin HC, Wu YH, Huang CW, Ker MD. Lin HC, et al. Among authors: wu yh. Brain Res. 2023 Jan 1;1798:148165. doi: 10.1016/j.brainres.2022.148165. Epub 2022 Nov 12. Brain Res. 2023. PMID: 36379316

10

COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells.

Wu YH, Huang YF, Chang TH, Chen CC, Wu PY, Huang SC, Chou CY. Wu YH, et al. Oncogene. 2021 Jul;40(26):4503-4519. doi: 10.1038/s41388-021-01865-8. Epub 2021 Jun 11. Oncogene. 2021. PMID: 34117361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year